Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William G Powderly

Showing results (51-60 of 142) with videos related to

Pageof 15
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 4, 2020
Brief Report: Integrase Strand Transfer Inhibitors Are Associated With Lower Risk of Incident Cardiovascular Disease in People Living With HIVJane A O'Halloran, John Sahrmann, Anne M Butler, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 15, 2017
Invasive Fungal Infections Secondary to Traumatic InjuryRyan Kronen, Stephen Y Liang, Grant Bochicchio, et al.
Spine|November 2, 2006
Nontuberculous pyogenic spinal infection in adults: a 12-year experience from a tertiary referral centerJoseph S Butler, Martin J Shelly, Marcus Timlin, et al.
Journal of Clinical and Translational Science|June 30, 2021
Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemicsBarry S Coller, John B Buse, Robert P Kimberly, et al.
HIV Clinical Trials|June 15, 2010
A microsimulation of the cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individualsFelicitas C Kühne, Jeremy Chancellor, Patrick Mollon, et al.
Current Opinion in HIV and AIDS|June 1, 2012
Current advances in pharmacovigilance in the USA and Europe: meeting the challenges of safety monitoring in HIVKendall A Marcus, Alfred Sorbello, Melissa Truffa, et al.
The Journal of Infectious Diseases|August 29, 2002
Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategiesPablo Tebas, Keith Henry, Kristin Mondy, et al.
Plos Pathogens|June 24, 2022
Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19Daniel Clark Files, Frank Tacke, Alexandra O'Sullivan, et al.
The Journal of Infectious Diseases|September 14, 2020
Pathways to Leadership: Reflections of Recent Infectious Diseases Society of America (IDSA) Leaders During Conception and Launch of the Inclusion, Diversity, Access, and Equity Movement Within the IDSACynthia L Sears, William G Powderly, Paul G Auwaerter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2005
Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosisSomnuek Sungkanuparph, E Turner Overton, Warren Seyfried, et al.
Pageof 15

Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Journal of Acquired Immune Deficiency Syndromes (1999)|April 4, 2020
Brief Report: Integrase Strand Transfer Inhibitors Are Associated With Lower Risk of Incident Cardiovascular Disease in People Living With HIVJane A O'Halloran, John Sahrmann, Anne M Butler, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 15, 2017
Invasive Fungal Infections Secondary to Traumatic InjuryRyan Kronen, Stephen Y Liang, Grant Bochicchio, et al.
Spine|November 2, 2006
Nontuberculous pyogenic spinal infection in adults: a 12-year experience from a tertiary referral centerJoseph S Butler, Martin J Shelly, Marcus Timlin, et al.
Journal of Clinical and Translational Science|June 30, 2021
Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemicsBarry S Coller, John B Buse, Robert P Kimberly, et al.
HIV Clinical Trials|June 15, 2010
A microsimulation of the cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individualsFelicitas C Kühne, Jeremy Chancellor, Patrick Mollon, et al.
Current Opinion in HIV and AIDS|June 1, 2012
Current advances in pharmacovigilance in the USA and Europe: meeting the challenges of safety monitoring in HIVKendall A Marcus, Alfred Sorbello, Melissa Truffa, et al.
The Journal of Infectious Diseases|August 29, 2002
Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategiesPablo Tebas, Keith Henry, Kristin Mondy, et al.
Plos Pathogens|June 24, 2022
Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19Daniel Clark Files, Frank Tacke, Alexandra O'Sullivan, et al.
The Journal of Infectious Diseases|September 14, 2020
Pathways to Leadership: Reflections of Recent Infectious Diseases Society of America (IDSA) Leaders During Conception and Launch of the Inclusion, Diversity, Access, and Equity Movement Within the IDSACynthia L Sears, William G Powderly, Paul G Auwaerter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2005
Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosisSomnuek Sungkanuparph, E Turner Overton, Warren Seyfried, et al.
Pageof 15